Avalo Therapeutics (AVTX) Capital Expenditures (2016 - 2023)
Avalo Therapeutics (AVTX) posted Capital Expenditures of $158000.0 for Q1 2023, up 66.32% on a QoQ basis from $95000.0 in Q4 2022.
Avalo Therapeutics (AVTX) Capital Expenditures (2016 - 2023) Analysis & Trends
Avalo Therapeutics' Capital Expenditures history runs 8 years deep, the most recent figure standing at $158000.0 for Q1 2023.
- Quarterly Capital Expenditures changed N/A year-over-year to $158000.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $158000.0 (up 66.32% YoY) and the FY2023 annual result came in at $158000.0, up 66.32% from the prior year.
- Capital Expenditures was $158000.0 for Q1 2023 at Avalo Therapeutics, up from $95000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $2.0 million in Q3 2021 and bottomed at -$1.0 million in Q4 2021.
- A 5-year average of $131501.1 and a median of $59500.0 in 2020 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2020 — Capital Expenditures soared 3149900.0% — and 2021, when it plunged 1687.3%.
- Avalo Therapeutics' Capital Expenditures stood at $2.0 in 2019, then surged by 3149900.0% to $63000.0 in 2020, then plunged by 1687.3% to -$1.0 million in 2021, then jumped by 109.5% to $95000.0 in 2022, then soared by 66.32% to $158000.0 in 2023.
- Business Quant data shows AVTX's Capital Expenditures at $158000.0 in Q1 2023, $95000.0 in Q4 2022, and -$56000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 158,000.00 |
| Mar 31, 2023 | 158,000.00 |
| Dec 31, 2022 | 95,000.00 |
| Dec 31, 2022 | 95,000.00 |
| Sep 30, 2022 | -56,000.00 |
| Sep 30, 2022 | -56,000.00 |
| Jun 30, 2022 | 56,000.00 |
| Jun 30, 2022 | 56,000.00 |
| Dec 31, 2021 | -1.00 Mn |
| Dec 31, 2021 | -1.00 Mn |
| Sep 30, 2021 | 1.98 Mn |
| Sep 30, 2021 | 1.98 Mn |
| Mar 31, 2021 | 21,000.00 |
| Mar 31, 2021 | 21,000.00 |
| Dec 31, 2020 | 63,000.00 |
| Dec 31, 2020 | 63,000.00 |
| Dec 31, 2019 | 2.00 |
| Dec 31, 2019 | 2.00 |
| Sep 30, 2019 | 5,085.00 |
| Sep 30, 2019 | 5,085.00 |